Published in Infect Immun on October 01, 1989
Characterization of a protective protein antigen of Erysipelothrix rhusiopathiae. Epidemiol Infect (1991) 0.91
Detection of cytokine activated chondrocytes in arthritic joints from pigs infected with Erysipelothrix rhusiopathiae. Ann Rheum Dis (1992) 0.75
Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med (1977) 10.09
Cachectin: more than a tumor necrosis factor. N Engl J Med (1987) 8.74
Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med (1985) 8.16
Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med (1988) 7.96
Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet (1981) 6.62
Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature (1988) 6.18
Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J Immunol (1985) 5.38
Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem (1988) 4.44
Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J Exp Med (1987) 4.35
Arthritis associated with Yersinia enterocolitica infection. Acta Rheumatol Scand (1969) 4.03
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med (1988) 4.02
Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells. J Clin Invest (1979) 3.34
Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol (1988) 2.58
Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int (1982) 2.24
Tumor necrosis factor mediates endotoxic effects in mice. Infect Immun (1987) 2.10
Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A (1982) 1.99
Acute inflammation in gram-negative infection: endotoxin, interleukin 1, tumor necrosis factor, and neutrophils. Fed Proc (1987) 1.90
Identification of immunostimulatory dendritic cells in the synovial effusions of patients with rheumatoid arthritis. J Clin Invest (1985) 1.47
Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies. J Clin Invest (1986) 1.46
Cytokines and other mediators in rheumatoid arthritis. Springer Semin Immunopathol (1984) 1.45
Induction of human interleukin 1 by bacterial and synthetic lipid A. Eur J Immunol (1986) 1.36
Reiter's syndrome following epidemic shigellosis. J Rheumatol (1982) 1.23
Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide. J Immunol (1988) 1.21
Spontaneous production of fibroblast-activating factor(s) by synovial inflammatory cells. A potential mechanism for enhanced tissue destruction. J Exp Med (1985) 1.20
Characterization of blood mononuclear cells of rheumatoid arthritis patients. I. Depressed lymphocyte proliferation and enhanced prostanoid release from monocytes. Clin Immunol Immunopathol (1982) 1.18
Recombinant human tumor necrosis factor induces acute reductions in food intake and body weight in mice. J Exp Med (1988) 1.16
Macrophage cytotoxicity: interleukin 1 as a mediator of tumor cytostasis. J Immunol (1986) 1.13
Erythrocyte catabolism by macrophages in vitro. The effect of hydrocortisone on erythrophagocytosis and on the induction of heme oxygenase. J Clin Invest (1973) 1.12
Erysipelothrix arthritis in swine: bacteriologic and immunopathologic aspects. Am J Vet Res (1970) 1.12
Development of an experimental animal model for reactive arthritis induced by Yersinia enterocolitica infection. Infect Immun (1987) 1.12
Collagen autoimmunity and arthritis. FASEB J (1988) 1.11
Heberden Oration 1980: aspects of the cell biology of the rheumatoid synovial lesion. Ann Rheum Dis (1981) 1.11
Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics. J Clin Invest (1984) 1.11
Synergy between adjuvant arthritis and collagen-induced arthritis in rats. J Exp Med (1985) 1.05
Macrophage activation in rat models of inflammation and arthritis. Systemic activation precedes arthritis induction and progression. Arthritis Rheum (1986) 1.02
Induction of prostaglandin E release from macrophages by colchicine. J Immunol (1980) 0.95
Host responses to infection with Yersinia enterocolitica. Contrib Microbiol Immunol (1979) 0.94
Induction of experimental chronic arthritis in rabbits by cell-free fragments of Erysipelothrix. J Bacteriol (1969) 0.90
Role of interleukin 1 and interleukin 2 in rat and mouse arthritis models. J Immunol (1986) 0.89
Suppression of T lymphocyte proliferation during lymphoma growth in mice: role of PGE2-producing suppressor macrophages. Immunobiology (1982) 0.81
Prostaglandin synthesis by lymphoid tissue of mice experiencing a graft-versus-host reaction: relationship to immunosuppression. Cell Immunol (1980) 0.79
Characterization of blood mononuclear cells of rheumatoid arthritis patients. II. Depressed PPD presentation by monocytes to T lymphocytes. Clin Immunol Immunopathol (1983) 0.79
Effects of cyclosporin A on functions of specific murine T cell clones: inhibition of proliferation, lymphokine secretion and cytotoxicity. Immunobiology (1986) 0.78
Interleukin 1 as a tumor cytostatic mediator released from tumor ascites-treated macrophages. Immunobiology (1988) 0.76
Detection of arthritogenic factor in adjuvant arthritis. J Immunol (1988) 0.76
[Immunopathologic aspects of chronic erysipelas polyarthritis in swine]. Z Rheumatol (1983) 0.76
Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing. Cell (1987) 5.80
Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice. Nat Genet (1996) 4.15
An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A (1996) 3.79
Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans. Proc Natl Acad Sci U S A (1996) 3.50
Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J Immunol (1982) 3.24
Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest (1993) 3.13
Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat Genet (1997) 2.97
Starvation induces vacuolar targeting and degradation of the tryptophan permease in yeast. J Cell Biol (1999) 2.80
An intrinsic bond-centered electronic glass with unidirectional domains in underdoped cuprates. Science (2007) 2.76
Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol (1988) 2.58
A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis. Mol Cell Biol (1987) 2.36
Identification of a polyketide synthase gene (pksP) of Aspergillus fumigatus involved in conidial pigment biosynthesis and virulence. Med Microbiol Immunol (1998) 2.36
The nucleotide sequence of the mercuric resistance operons of plasmid R100 and transposon Tn501: further evidence for mer genes which enhance the activity of the mercuric ion detoxification system. Mol Gen Genet (1986) 2.34
Virulence and hyphal formation of Candida albicans require the Ste20p-like protein kinase CaCla4p. Curr Biol (1997) 2.33
Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension. Circulation (1998) 2.28
How Cooper pairs vanish approaching the Mott insulator in Bi2Sr2CaCu2O8+delta. Nature (2008) 2.27
Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. Exp Hematol (1987) 2.25
Characterization of two soybean repetitive proline-rich proteins and a cognate cDNA from germinated axes. Plant Cell (1989) 2.06
Cell wall integrity modulates RHO1 activity via the exchange factor ROM2. EMBO J (1998) 2.04
Reporter constructs with low background activity utilizing the cat gene. Gene (1992) 2.02
The small GTP-binding protein rab6 functions in intra-Golgi transport. J Cell Biol (1994) 2.02
Interleukin-1 costimulatory activity on the interleukin-2 promoter via AP-1. Science (1989) 2.01
Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol (1997) 2.00
Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology (1994) 1.98
Isolation of two interferon-induced translational inhibitors: a protein kinase and an oligo-isoadenylate synthetase. Proc Natl Acad Sci U S A (1978) 1.97
[Correlation of growth hormone and aetiology of psoriasis]. Arch Dermatol Res (1981) 1.97
Biological activities of EGF-receptor mutants with individually altered autophosphorylation sites. EMBO J (1988) 1.92
Regulation of a collagen gene promoter by the product of viral mos oncogene. Nature (1985) 1.85
Lipids, lipid modification and lipid-protein interaction in membrane budding and fission--insights from the roles of endophilin A1 and synaptophysin in synaptic vesicle endocytosis. Curr Opin Neurobiol (2000) 1.85
Isolation and characterization of a pigmentless-conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence. Infect Immun (1997) 1.82
A sequence conserved in both the chicken and mouse alpha 2(I) collagen promoter contains sites sensitive to S1 nuclease. J Biol Chem (1984) 1.81
Interferon action: isolation of nuclease F, a translation inhibitor activated by interferon-induced (2'-5') oligo-isoadenylate. FEBS Lett (1978) 1.80
The Rho1 effector Pkc1, but not Bni1, mediates signalling from Tor2 to the actin cytoskeleton. Curr Biol (1998) 1.78
Identification and characterization of a novel extracellular matrix protein nephronectin that is associated with integrin alpha8beta1 in the embryonic kidney. J Cell Biol (2001) 1.77
Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor. Proc Natl Acad Sci U S A (1997) 1.76
HEAT repeats mediate plasma membrane localization of Tor2p in yeast. J Biol Chem (2000) 1.75
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. Heart (2001) 1.74
A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome. Am J Hum Genet (1992) 1.73
Mercuric reductase structural genes from plasmid R100 and transposon Tn501: functional domains of the enzyme. Gene (1985) 1.68
A cyclic AMP response element mediates repression of tyrosine aminotransferase gene transcription by the tissue-specific extinguisher locus Tse-1. Cell (1990) 1.67
Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab (1999) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
The safety and efficacy of an extravascular, water-soluble sealant for vascular closure: initial clinical results for Mynx. Catheter Cardiovasc Interv (2007) 1.63
p53 and K-RAS alterations in pancreatic epithelial cell lesions. Oncogene (1993) 1.62
Transcriptional control of the mouse alpha 2(I) collagen gene: functional deletion analysis of the promoter and evidence for cell-specific expression. Mol Cell Biol (1986) 1.60
The mechanism of photosynthetic sulfate reduction by isolated chloroplasts. Biochim Biophys Acta (1969) 1.56
High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells. J Bone Miner Res (1998) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Kinetics of the induction of three translation-regulatory enzymes by interferon. Proc Natl Acad Sci U S A (1979) 1.56
Binding of AP-1 Golgi adaptors to membranes requires phosphorylated cytoplasmic domains of the mannose 6-phosphate/insulin-like growth factor II receptor. J Biol Chem (1993) 1.53
Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha. J Immunol (1988) 1.53
1.7 A structure of the stabilized REIv mutant T39K. Application of local NCS restraints. Acta Crystallogr D Biol Crystallogr (1999) 1.53
Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running. Clin Immunol Immunopathol (1992) 1.51
Kinetics of the transformation of Gram-negative rods to spheroplasts and ghosts by serum. J Immunol (1966) 1.51
Cell type-specific desmosomal plaque proteins of the plakoglobin family: plakophilin 1 (band 6 protein). Differentiation (1994) 1.51
Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response. J Leukoc Biol (1997) 1.51
Occupational skin diseases in Northern Bavaria between 1990 and 1999: a population-based study. Br J Dermatol (2001) 1.51
Reduction of adenosine 5'-phosphosulfate to cysteine in extracts from Chlorella and mutants blocked for sulfate reduction. Eur J Biochem (1974) 1.50
Chemokine receptor (CCR5) expression in human kidneys and in the HIV infected macaque. Kidney Int (1998) 1.50
[Developments in chromate allergy in the German construction industry]. Hautarzt (2004) 1.50
Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am J Physiol Cell Physiol (2004) 1.49
Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48
An angiogenic growth factor is expressed in human glioma cells. EMBO J (1987) 1.46
Chemotaxis of polymorphonuclear neutrophils (PMN) in patients suffering from recurrent infection. Eur J Clin Invest (1993) 1.46
The interferon-induced protein kinase PK-i from mouse L cells. J Biol Chem (1979) 1.45
[Interstitial Nd:YAG laser therapy. Color-Doppler imaging (CDI)-guided laser therapy of hemangiomas and vascular malformations]. HNO (2003) 1.45
Evidence for epidermal growth factor (EGF)-induced intermolecular autophosphorylation of the EGF receptors in living cells. Mol Cell Biol (1990) 1.42
[Resection of liver metastases of colorectal carcinoma: claims and reality]. Dtsch Med Wochenschr (1991) 1.42
POU domain factor Brn-3a controls the differentiation and survival of trigeminal neurons by regulating Trk receptor expression. Development (1999) 1.41
An interferon-induced phosphodiesterase degrading (2'-5') oligoisoadenylate and the C-C-A terminus of tRNA. Proc Natl Acad Sci U S A (1979) 1.40
DNA sequence comparison of the regulatory signals at the 5' end of the mouse and chick alpha 2 type I collagen genes. J Biol Chem (1984) 1.40
Influenza A virus infection of macrophages. Enhanced tumor necrosis factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered TNF-alpha release. J Immunol (1991) 1.39
Role of macrophage cytokines in influenza A virus infections. Immunobiology (1993) 1.39
Synthesis and biological testings as inhibitors of HMGCoA reductase of the seco-acid of tuckolide and its C-7 epimer. Bioorg Med Chem (1999) 1.39
[Circumcision for boys incapable of giving informed consent]. Urologe A (2009) 1.39
Bloodstream infections caused by small-colony variants of coagulase-negative staphylococci following pacemaker implantation. Clin Infect Dis (1999) 1.39
Comments on "Can stress cause depression?" by H.M. van Praag. Progress in Neuro-Psychopharmacology and Biological Psychiatry 28 (2004) 891-907. Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.38
Traffic casualties. I. Physical and social sequelae: a follow-up of 3000 traffic accidents. Dan Med Bull (1972) 1.38
Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides. J Immunol (1990) 1.36
Sulfate reduction in a cell-free system of Chlorella. The ferredoxin dependent reduction of a protein-bound intermediate by a thiosulfonate reductase. Arch Mikrobiol (1973) 1.35
Further delineation of the Nijmegen breakage syndrome. Am J Med Genet (1989) 1.35
Interleukin 1 and the glomerular mesangium. I. Purification and characterization of a mesangial cell-derived autogrowth factor. J Immunol (1986) 1.34
Developmental and tissue-specific expression directed by the alpha 2 type I collagen promoter in transgenic mice. Proc Natl Acad Sci U S A (1986) 1.34
Contaminants in sediments: remobilisation and demobilisation. Sci Total Environ (2001) 1.33
Salt restriction induces pseudohypoaldosteronism type 1 in mice expressing low levels of the beta-subunit of the amiloride-sensitive epithelial sodium channel. Proc Natl Acad Sci U S A (1999) 1.33
DnaA protein binding to individual DnaA boxes in the Escherichia coli replication origin, oriC. EMBO J (1997) 1.33
The widespread human desmocollin Dsc2 and tissue-specific patterns of synthesis of various desmocollin subtypes. Eur J Cell Biol (1995) 1.32
Chemokines in the cerebrospinal fluid of patients with meningitis. Clin Immunol Immunopathol (1996) 1.31
Electronic health records: new opportunities for clinical research. J Intern Med (2013) 1.31